Can we change the course of beta-cell destruction in type 1 diabetes?
Gale
Edwin A M
EA
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D017252:CD3 Complex / Q000276:immunology*; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy / Q000235:genetics / Q000517:prevention & control*; D005190:Family; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007328:Insulin / Q000627:therapeutic use*; D007515:Islets of Langerhans / Q000276:immunology; D012307:Risk Factors
D000911:Antibodies, Monoclonal; D017252:CD3 Complex; D007004:Hypoglycemic Agents; D007328:Insulin